However, it may not be advisable to enter the stock at this juncture, as the valuation appears rich. At 22 times its trailing 12-month earnings, the stock trades at a price-earnings multiple that is comparable to frontline FMCG companies.
http://c.moreover.com/click/here.pl?r429445177
http://c.moreover.com/click/here.pl?r429445177